[Clinical observation of cidofovir in salvage therapy for cytomegalovirus infection in patients with haploid hematopoietic stem cell transplantation]

Zhonghua Xue Ye Xue Za Zhi. 2020 Apr 14;41(4):326-330. doi: 10.3760/cma.j.issn.0253-2727.2020.04.013.

[Article in Chinese]

Authors

Z Yin¹, G P Yu¹, N Xu¹, L Jiang¹, F Huang¹, Z P Fan¹, Z X Wang¹, L Xuan¹, Q F Liu¹, J Sun¹

Affiliation

¹ Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.

PMID: 32447939
PMCID: PMC7364930
DOI: 10.3760/cma.j.issn.0253-2727.2020.04.013

No abstract available

MeSH terms

Cidofovir / therapeutic use*
Cytomegalovirus Infections* / drug therapy
Cytomegalovirus Infections* / etiology
Haploidy
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Salvage Therapy

Substances

Cidofovir